1.Guo BJ#, Jiang MC#, Guo X#, Tang CX#, Zhong J, Lu MJ, Liu CY, Zhang XL, Qiao H, Zhou F, Xu PP, Xue Y, Zheng MW, Hou Y, Wang YN, Zhang JY, Zhang B, Zhang DM, Xu L, Hu XH, Zhou C, Li JH, ZW, Mao XS, Lu G*, Zhang LJ*.Diagnostic and prognostic performance of artificial intelligence-based fully-automated on-site CT-FFR in patients with CAD. Sci Bull (Beijing). 2024, 69(10):1472-1485.[IF=18.8]
2.Zhu L#, Li J#, Pan J, Wu N, Xu Q, Zhou QQ, Wang Q, Han D, Wang Z, Xu Q, Liu X, Guo J, Wang J, Zhang Z, Wang Y, Cai H, Li Y, Pan H*, Zhang L*, Chen X*, Lu G*. Precise Identification of Glioblastoma Micro-Infiltration at Cellular Resolution by Raman Spectroscopy.Adv Sci (Weinh).2024 Jul 31:e2401014.[IF=14.3]
3.Guo B#, Xing W#, Hu C, Zha Y, Yin X, He Y, Hu S, Shi Y, Lv F, Wang R, Li X, Gu H, Cao W, Zhang J, Zhou Y, Xu Y, Jiang MC, Zhong J, Zhang J, Chen M, Xie B, Chen Q, Diao W, Qiao H, Zhang Y, Xia R, Liu X, Tao SM, Zhang T, Yin CQ, Li W, Zhu M, Zhou CS, Li JH, Zhou F, Liu CY, Zhang XL, Xu PP, Zhang W, Lu MJ, Liu YX, Wei Y, Chen Y, Tang CX, Lu GM*, Zhang LJ*; China CT-FFR Study 3 Group. Clinical Effectiveness of Automated Coronary CT-derived Fractional Flow Reserve: A Chinese Randomized Controlled Trial. Radiology. 2024, 313(1):e233354.[IF=12.1]
4.Qing-Qing Zhou,Jingxing Guo,Ziyang Wang,Jianrui Li,Meng Chen,Qiang Xu,Lijun Zhu,Qing Xu,Qiang Wang,Hao Pan,Jing Pan,Yong Zhu,Ming Song,Xiaoxue Liu,Jiandong Wang,Zhiqiang Zhang,Longjiang Zhang,Yiqing Wang,Huiming Cai,Xiaoyuan Chen*, Guangming Lu*.Rapid visualization of PD-L1 expression level in glioblastoma immune microenvironment via machine learning cascade-based Raman histopathology.J Adv Res.2024 Nov:65:257-271. [IF=11.4]
5.Jingxing Guo, Ying Liu, Huangxian Ju*, Guangming Lu*.From lab to field: surface-enhanced Raman scattering-based sensing strategies for on-site analysis.TrAC Trends in Analytical Chemistry.2022 Jan; 146: 116488. [IF=11.8]
6.Xu Q, Zhan X, Zhou Z, Li Y, Xie P, Zhang S, Li X, Yu Y, Zhou C, Zhang L, Gevaert O*, Lu G*. AI-based analysis of CT images for rapid triage of COVID-19 patients.NPJ Digit Med .2021 Apr 22;4(1):75.[IF=12.4]
7.Liu Y, Zhou C, Zhang F, Zhang Q, Wang S, Zhou J, Sheng F, Wang X, Liu W, Wang Y, Yu Y*, Lu G*.Compare and contrast: Detecting mammographic soft-tissue lesions with C2-Net.Med Image Anal.2021 Jul;71:101999.[IF=10.7]
8.Ying Tian, Muhammad Rizwan Younis, Yuxia Tang, Xiang Liao, Gang He, Shouju Wang, Zhaogang Teng, Peng Huang, Longjiang Zhang* and Guangming Lu*.Dye-loaded mesoporous polydopamine nanoparticles for multimodal tumor theranostics with enhanced immunogenic cell death.Journal of Nanobiotechnology.2021 Nov 17;19(1):365. [IF=10.6]
9.Tang Y, Zhang J, He D, Miao W, Liu W, Li Y, Lu G*, Wu F*, Wang S*. GANDA: A deep generative adversarial network conditionally generates intratumoral nanoparticles distribution pixels-to-pixels.J Control Release.2021 Aug 10;336:336-343.[IF=10.5]
10.Peng, X.Chen, K.Liu, W. H*.Cao, X. F.Wang, M. R.Tao, J.Tian, Y.Bao, L.Lu, G*. M.Teng, Z*. G Soft Mesoporous Organosilica Nanoplatforms Improve Blood Circulation, Tumor Accumulation/Penetration, and Photodynamic Efficacy.Nano-Micro Letters.2020, 12(1): 19.[IF=31.6]
